Alzheimer patients
Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals
... latory Alzheimer patients’ compliance and other out- comes such as knowledge in pharmacotherapy and caregivers’ health-related quality of ...Germany. Patients had to fulfil the following inclusion ...
9
Potential drug–drug interactions in Alzheimer patients with behavioral symptoms
... Alzheimer patients present an increased risk of ADRs and drug–drug interaction ADRs due to several factors such as age, age of disease onset, the presence of multi-pharmaco- therapy as well as ...
10
Effectiveness of Gestalt Group Therapy on Loneliness of Women Caregivers of Alzheimer Patients at Home
... Gestalt therapy as an approach is based on current consciousness and integration of mind, body and emotions. The first task of Gestalt therapy is to initiate awareness (18). This treatment type is designed to help a ...
5
Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics
... AD patients and 246 controls. All patients had been referred to the memory clinic of the Alzheimer center of the VU University Medical Center, Amsterdam, the Netherlands between September 2003 and ...
7
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients
... Results of this study suggest that isoprenoid regulation may be speci fically altered in AD. This conclusion is based on the following. Both FPP and GGPP levels were signi ficantly higher in brain tissue of male AD ...
7
Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects
... much larger degree than previously possible. One brain region affected by Alzheimer’s disease, the temporal cortex, was selected from different AD patients and control subjects, and an extensive statistical ...
11
Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects
... For model 2, the model that focused on ventricular and supraventricular regions, the discriminant function analysis selected two variables: the area of the third ventricle on slice 3 and[r] ...
7
Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation
... From the Neurodegenerative Brain Diseases Group (T.V.d.B., K.S., E.C., A.S., A.D.R., C.V.C., S.V., M.V.d.B., A.L., K.P., M.M., C.V.B.), Department of Molecular Genetics, VIB, Antwerp; Institute Born-Bunge (T.V.d.B., ...
10
Applying the Rhetorical Structure Theory in Alzheimer patients’ speech
... Notwithstanding this, in the treatment of linguis- tics deficits, interesting proposals have started to be formulated such as Kong et al. (2017). They used RST in narrations and descriptions of aphasia pa- tients and ...
5
Comparison of Quantitative EEG Indices of the Patients with Alzheimer and Parkinson
... in Alzheimer and Parkinson ...AD patients compared to PDD ones, and there was significant difference between these groups and the control group in this ...for Alzheimer patients ...PDD ...
5
Oxidative Markers and Antioxidant Defences in Patients Diagnosed with Probable Alzheimer Disease
... INTRODUCTION: Increasing evidence suggests that oxidative stress is associated with aging and several neurodegenerative diseases, including Alzheimer's disease (AD), although the role of oxidative stress in the aetiology ...
5
Alzheimer s Disease. Alzheimer s Disease. Goals & Objectives
... Scientists are continuing this research through the Dominantly Inherited Alzheimer Network (DIAN), an international partnership to study families with a genetic mutation that causes early-onset Alzheimer's ...
53
COGNITIVE CHANGES AND BASAL THYROTROPIN IN TREATED AND UNTREATED PATIENTS WITH ALZHEIMER S DISEASE
... 17 patients treated with cholinesterase inhibitors (Group A), 16 patients treated with tacrine (Group B), 15 patients treated with various nootropics (Group C) and 53 patients under no ...
5
Mutation screening of patients with Alzheimer disease identifies APP locus duplication in a Swedish patient
... Twenty-two patients were referred for mutation screening in the genes APP, PSEN1, PSEN2 at the Genetics Unit as part of the clinical investigation at the Dept of Geriatric Medicine, Karolinska University Hospital, ...
9
Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease
... Several reasons may account for these discrepancies, eg, the numerosity and characteristics of both patients and caregivers and the setting of patients (ie, hospital, rehabilitation ward, outpatients). ...
7
Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors
... patients compared with AChE from non-AD groups, includ- ing patients with other forms of dementia (21). A correlation was found between the expression of the amyloid β (Aβ), the levels of AChE and ...
6
α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients
... The amyloid precursor protein (APP) is a crucial el- ement in the amyloid cascade and in the pathogene- sis of Alzheimer Disease (AD). It can be processed by different pathways involving either , , or cleavage. ...
8
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
... mean patients’ age among the studies included in the meta-analysis were very similar (Table 1), we did not perform the meta- regression analysis to examine whether the effect size of memantine was associated with ...
20
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
... Abstract: Early-onset Alzheimer’s disease (EOAD) has distinct clinical characteristics in com- parison to late-onset Alzheimer’s disease (LOAD). The genetic contribution is suggested to be more potent in EOAD. However, ...
6
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
... of patients receiving galantamine and 61% of patients receiving donepezil took the highest maintenance dose (galantamine 24 mg/d or donepezil 10 mg/d) at the endpoint in this ...AD patients, and ...
8